| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/31/2013 | CN102134562B Construction and screening of rabies virus Evelyn-Rokitnicki-Abelseth (ERA) attenuated live vaccine candidate strain |
| 07/31/2013 | CN101899417B Adefovir resistant mutant virus strain of hepatitis B virus and application thereof |
| 07/31/2013 | CN101695572B Method for producing pseudorabies attenuated vaccine by using bioreactor and pseudorabies attenuated vaccine product |
| 07/30/2013 | US8497112 Method for producing viral vaccines |
| 07/30/2013 | CA2691091C Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 07/25/2013 | US20130189762 Multi plasmid system for the production of influenza virus |
| 07/25/2013 | US20130189306 Flavivirus Vaccines |
| 07/25/2013 | US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 07/25/2013 | US20130189265 Modified parvovirus having enhanced anti-tumor efficacy |
| 07/24/2013 | EP2616087A2 Antibacterial phage, phage peptides and methods of use thereof |
| 07/24/2013 | CN1705740B Adenovirus expressing genes in reverse order and use thereof |
| 07/24/2013 | CN103215234A Adenovirus with zinc finger nuclease expression element and donor DNA, and construction method and application |
| 07/24/2013 | CN103215233A Optimized process method for amplifying enterovirus type 71 by use of bioreactor |
| 07/24/2013 | CN103215226A Method for co-culturing with nerve stem cell to inducing rASCs to be DA Neuron by Lmx1a mediation |
| 07/24/2013 | CN103215225A Construction method of glial cell line-derived neurotrophic factor gene-modified embryo neural stem cell |
| 07/24/2013 | CN103214570A Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or Nl-subtype and uses thereof |
| 07/24/2013 | CN102533677B Malaria vaccine and preparation method thereof |
| 07/24/2013 | CN102268454B Prostate specific membrane antigen (PSMA) recombinant adeno-associated virus vector and its construction method and use |
| 07/23/2013 | US8492532 Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone |
| 07/23/2013 | US8492132 Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PPRS) virus and uses thereof |
| 07/23/2013 | US8491916 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142 |
| 07/23/2013 | CA2537793C Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 07/23/2013 | CA2469644C Method for large scale production of virus antigen |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/18/2013 | WO2013106548A1 Methods and cells for the production of viral vaccines |
| 07/18/2013 | WO2013106525A1 Immunogenic hpv l2-containing vlps and related compositions and methods |
| 07/18/2013 | WO2013106398A1 Purification of herpes virus |
| 07/18/2013 | WO2013106337A1 Purification of flaviviruses |
| 07/18/2013 | WO2013105781A1 Novel isolated bacteriophage and antibacterial composition comprising same |
| 07/18/2013 | US20130184183 Recombinant bacteriophage and methods for their use |
| 07/18/2013 | US20130183742 Method for harvesting expression products |
| 07/18/2013 | US20130183740 Novel method for generation of rna virus |
| 07/18/2013 | US20130183271 Methods and Compositions Concerning Poxviruses and Cancer |
| 07/17/2013 | EP2615167A1 Method for eliminating DNA contaminants from viral preparations |
| 07/17/2013 | EP2614140A2 Mdck-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells |
| 07/17/2013 | CN103209706A Methods to produce bunyavirus replicon particles |
| 07/17/2013 | CN103205460A Chimeric virus, and preparation method and application thereof |
| 07/17/2013 | CN103205400A Recombinant lentiviral vector containing ubiquitin-specific protease gene USP39-shRNA (short hairpin ribonucleic acid) and application thereof |
| 07/17/2013 | CN103205399A Recombinant herpes simplex virus, and preparation method and application thereof |
| 07/17/2013 | CN102488893B Duck hemorrhagic oophoritis inactivated vaccine production method by using cell line and product thereof |
| 07/17/2013 | CN102295690B Disease tolerance related protein, and coding gene and application thereof |
| 07/17/2013 | CN102220288B Mouse-addapted enterovirus EV71 strain 573 and use thereof |
| 07/17/2013 | CN102120986B Cell culture method of rotavirus |
| 07/17/2013 | CN101506358B Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments |
| 07/16/2013 | US8486685 Cellular permissivity factor for viruses and uses thereof |
| 07/16/2013 | US8486420 Modified Rna virus packaged with structural proteins and second virus; induce immunology response |
| 07/16/2013 | US8486419 Flavivirus mutant has a deletion in the capsid protein of at least more than 4 successive amino acids, wherein the carboxy terminal hydrophobic region is not affected by the deletion |
| 07/16/2013 | US8486418 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 07/16/2013 | US8486417 Recombinant bicistronic Flavivirus vectors |
| 07/16/2013 | CA2517181C Methods of producing influenza vaccine compositions |
| 07/11/2013 | WO2013103808A1 Expression of negative sense rna viruses and double-stranded rna viruses, and uses thereof |
| 07/11/2013 | US20130177587 Functional influenza virus-like particles (vlps) |
| 07/11/2013 | US20130177582 Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus |
| 07/10/2013 | EP2612911A1 Composition for inducing pluripotent stem cell, and use thereof |
| 07/10/2013 | EP2612909A1 Method for producing virus vector |
| 07/10/2013 | EP2611920A2 Vesicular stomatitis viruses |
| 07/10/2013 | CN103194445A DNA (Deoxyribonucleic acid) segment and applications thereof in constructing HCV (hepatitis C virus) whole-genome expression animal model |
| 07/10/2013 | CN103194419A Microorganism and application thereof |
| 07/10/2013 | CN103194418A Method for preparing fat alkane and intermediate alkene |
| 07/10/2013 | CN103191444A Method for preparing HPV16L2 recombinant adenovirus vaccine |
| 07/10/2013 | CN102618505B Human rotavirus-A seed strain ZTR-68, and isolation, culture and identification thereof |
| 07/10/2013 | CN102154221B Preparation of porcine circovirus II-type virus seed and storage method thereof |
| 07/09/2013 | US8481693 Virus like particle purification |
| 07/09/2013 | US8481298 Separation matrix for viral purification |
| 07/09/2013 | US8481297 Compositions and methods of use of an oncolytic vesicular stomatitis virus |
| 07/09/2013 | US8481053 Compositions and methods for treating of microbial infections |
| 07/09/2013 | CA2430702C Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/04/2013 | WO2013102155A1 Cells for virus and protein production |
| 07/04/2013 | WO2013098364A1 Second generation virus-like particles (vlp) from epstein-barr viruses for vaccination purposes |
| 07/04/2013 | WO2013056250A3 Cxcr4 inhibiting carriers for nucleic acid delivery |
| 07/04/2013 | WO2012117116A3 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses |
| 07/04/2013 | US20130171719 Recombinant aav production in mammalian cells |
| 07/04/2013 | US20130171620 Viral variants and methods for detecting same |
| 07/04/2013 | US20130171150 Feline picorna virus and uses thereof |
| 07/03/2013 | EP2610345A1 Recombinant influenza virus-like particles (VLPS) produced in transgenic plants expressing hemagglutinin |
| 07/03/2013 | EP2608806A1 An epstein-barr-virus vaccine |
| 07/03/2013 | EP2608664A1 Crop protection agents containing insect-pathogenic viruses, in particular baculoviruses, and cellulose sulfate |
| 07/03/2013 | CN103189508A Composition for inducing pluripotent stem cell, and use thereof |
| 07/03/2013 | CN103189507A Adeno-associated virus virions for transferring genes into neural cells |
| 07/03/2013 | CN103184205A Xylanase S1xB and coding gene thereof |
| 07/03/2013 | CN103184204A Xylanase SoxB and coding gene thereof |
| 07/03/2013 | CN103184203A Xylanase AnxB and coding gene thereof |
| 07/03/2013 | CN103184195A Powder parvovirus maintenance medium and preparation method thereof |
| 07/03/2013 | CN103184194A Production of avian reovirus and vaccine by using mammalian cell line |
| 07/03/2013 | CN102344913B Construction of rabies virus G protein expression recombinant canine distemper virus CDV/R-20/8 vaccine strain |
| 07/03/2013 | CN102038944B Method for industrially producing swine fever live vaccine by using bioreactor |
| 07/03/2013 | CN101979516B Virus sampling liquid composition |
| 07/03/2013 | CN101914498B MDCK (Madin-Darby Canine Kidney) cell line for stably expressing highly pathogenic avian influenza virus (HPAIV) HA (Hemagglutinin) protein and application thereof |
| 07/03/2013 | CN101712949B gM-negative EHV-mutants without heterologous elements |
| 07/03/2013 | CN101695571B Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product |
| 07/03/2013 | CN101610787B Method for replicating influenza virus in culture |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101379183B Rescue of influenza virus |
| 07/02/2013 | US8475806 High titer recombinant influenza viruses for vaccines and gene therapy |
| 07/02/2013 | CA2505558C T cell receptor display |
| 07/02/2013 | CA2478508C Stable adenoviral vectors and methods for propagation thereof |
| 07/02/2013 | CA2446131C Composition and method for increasing cell density in cell cultures infected with lentivirus |
| 07/02/2013 | CA2421151C Modified vaccinia ankara virus variant |
| 07/02/2013 | CA2379012C In vitro reconstitution of segmented negative-strand rna viruses |
| 06/27/2013 | WO2013095965A1 Stable storage of enveloped viruses in histidine aqueous solution |